Sign in
4

Changes in Ownership

BridgeBio Pharma, Inc. Filed Acc 0001209191-23-030593

Director gave up 1,300 shares (to pay taxes)

  • Director acquired 3,759 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HOMCY CHARLES J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-16 Exercise or conversion : show line 1 in the form +3,759 1,222,127 D
2023-05-16 Shares withheld for taxes : show line 2 in the form −1,300 $14.09 $18,317 1,220,827 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-16 Exercise or conversion : show line 3 in the form Restricted Stock Units −3,759 11,280 D
Loading xslF345X04/doc4.xml…